PepGen Inc. PEPG 深 滬
已收盤 04-02 16:00:00 美东时间
1.73
-0.010
-0.57%
華盛通- 最 高1.79
- 今 開1.72
- 成交量 171.68万股
- 最 低 1.65
- 昨 收 1.74
- 總市值 1.20亿
- 52周最高 7.80
- 市盈率 靜 --
- 換手率 2.48%
- 52周最低 1.01
- 委 比 52.95%
- 總股本 6911.53万
- 歷史最高 20.00
- 量 比 0.25
- 振 幅 8.05%
- 歷史最低 0.8801
- 每 手 1
- 風險率 2.08%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 存储分歧大！花旗大砍17%将美光目标价从510降至425美元；Bernstein上调希捷科技目标价从500升至620美元
今日重点评级关注：Maxim Group：上调Theriva Biologics评级至"买入"，目标价1美元；HC Wainwright & Co.：维持Bicara Therapeutics"买入"评级，目标价从40美元升至42美元
04-01 16:34
Why Is PepGen Stock Sinking Tuesday?
PepGen stock drops after Phase 2 low-dose data show limited splicing correction; higher-dose cohorts and FDA hold remain key focus areas.
03-31 19:14
美股夜盘 | Oxbridge Re Holdings Limited涨54.48%，Cemtrex, Inc.涨16.34%
Oxbridge Re Holdings Limited涨54.48%；Cemtrex, Inc.涨16.34%；Affinity Bancshares, Inc.涨15.64%
03-31 15:01
美股夜盘 | 海天网络涨64.00%，Oxbridge Re Holdings Limited涨53.33%
海天网络涨64.00%；Oxbridge Re Holdings Limited涨53.33%；Cemtrex, Inc.涨19.75%
03-31 13:01
美股夜盘 | Oxbridge Re Holdings Limited涨54.48%，海天网络涨51.75%
Oxbridge Re Holdings Limited涨54.48%；海天网络涨51.75%；Polar Power, Inc.涨16.41%
03-31 10:02
美股夜盘 | 海天网络涨58.50%，Oxbridge Re Holdings Limited涨45.26%
海天网络涨58.50%；Oxbridge Re Holdings Limited涨45.26%；Polar Power, Inc.涨17.44%
03-31 09:01
美股夜盘 | 海天网络涨65.25%，Oxbridge Re Holdings Limited涨33.73%
PepGen Inc.涨-41.61%；Conduit Pharmaceuticals涨-20.86%；PMGC Holdings Inc.涨-13.20%
03-31 08:10
PepGen Announces Clinical Data From The 5 Mg/Kg Multiple Ascending Dose Cohort Of The Ongoing Phase 2 FREEDOM2-DM1 Trial In Patients With Myotonic Dystrophy Type 1; PGN-EDOM1 Was Generally Well-Tolerated With All Adverse Events Mild Or Moderate And No Serious Adverse Events Reported
PepGen Inc. (NASDAQ:PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases,
03-31 04:14
Valneva, Venture Global And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Dow futures up 1000 points. Valneva stock falls in pre-market. Pfizer and Valneva announce Phase 3 results for Lyme disease vaccine. Other stocks also down.
03-23 20:03
